- Home
- AVIR vs IBEX Comparison
AVIR vs IBEX Comparison
Compare AVIR & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- IBEX
- Stock Information
- Founded
- AVIR 2012
- IBEX 2017
- Country
- AVIR United States
- IBEX United States
- Employees
- AVIR N/A
- IBEX N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- IBEX EDP Services
- Sector
- AVIR Health Care
- IBEX Technology
- Exchange
- AVIR Nasdaq
- IBEX Nasdaq
- Market Cap
- AVIR 273.7M
- IBEX 307.4M
- IPO Year
- AVIR 2020
- IBEX 2020
- Fundamental
- Price
- AVIR $2.55
- IBEX $28.03
- Analyst Decision
- AVIR Hold
- IBEX Hold
- Analyst Count
- AVIR 1
- IBEX 2
- Target Price
- AVIR $6.00
- IBEX $27.00
- AVG Volume (30 Days)
- AVIR 532.5K
- IBEX 186.7K
- Earning Date
- AVIR 05-12-2025
- IBEX 05-08-2025
- Dividend Yield
- AVIR N/A
- IBEX N/A
- EPS Growth
- AVIR N/A
- IBEX 48.53
- EPS
- AVIR N/A
- IBEX 2.25
- Revenue
- AVIR N/A
- IBEX $535,666,000.00
- Revenue This Year
- AVIR N/A
- IBEX $7.73
- Revenue Next Year
- AVIR N/A
- IBEX $5.43
- P/E Ratio
- AVIR N/A
- IBEX $12.27
- Revenue Growth
- AVIR N/A
- IBEX 5.35
- 52 Week Low
- AVIR $2.60
- IBEX $13.61
- 52 Week High
- AVIR $4.15
- IBEX $27.83
- Technical
- Relative Strength Index (RSI)
- AVIR 37.12
- IBEX 62.28
- Support Level
- AVIR $2.66
- IBEX $27.45
- Resistance Level
- AVIR $3.01
- IBEX $32.08
- Average True Range (ATR)
- AVIR 0.15
- IBEX 1.38
- MACD
- AVIR -0.03
- IBEX 0.39
- Stochastic Oscillator
- AVIR 7.02
- IBEX 51.73
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.